These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 17212640
1. Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection. Caini P, Guerra CT, Giannini C, Giannelli F, Gragnani L, Petrarca A, Solazzo V, Monti M, Laffi G, Zignego AL. J Viral Hepat; 2007 Jan; 14(1):22-8. PubMed ID: 17212640 [Abstract] [Full Text] [Related]
2. Effect of chronic hepatitis C virus infection on inflammatory lipid mediators. Guerra CT, Caini P, Giannini C, Giannelli F, Gragnani L, Petrarca A, Solazzo V, Monti M, Laffi G, Zignego AL. Dig Liver Dis; 2007 Sep; 39 Suppl 1():S76-82. PubMed ID: 17936229 [Abstract] [Full Text] [Related]
3. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin. Papavasiliou EC, Gouva C, Siamopoulos KC, Tselepis AD. Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163 [Abstract] [Full Text] [Related]
4. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles. Mitsios JV, Vini MP, Stengel D, Ninio E, Tselepis AD. Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1907-13. PubMed ID: 16728656 [Abstract] [Full Text] [Related]
5. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease. Ninio E, Tregouet D, Carrier JL, Stengel D, Bickel C, Perret C, Rupprecht HJ, Cambien F, Blankenberg S, Tiret L. Hum Mol Genet; 2004 Jul 01; 13(13):1341-51. PubMed ID: 15115767 [Abstract] [Full Text] [Related]
6. Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice. Singh U, Zhong S, Xiong M, Li TB, Sniderman A, Teng BB. Clin Sci (Lond); 2004 Apr 01; 106(4):421-32. PubMed ID: 14717654 [Abstract] [Full Text] [Related]
7. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase. Tsironis LD, Mitsios JV, Milionis HJ, Elisaf M, Tselepis AD. Cardiovasc Res; 2004 Jul 01; 63(1):130-8. PubMed ID: 15194469 [Abstract] [Full Text] [Related]
8. Bovine platelet-activating factor acetylhydrolase (PAF-AH) activity related to fertility. Turk R, Juretić D, Geres D, Bacić G, Milesević M, Flegar-Mestrić Z, Turk N, Svetina A. Anim Reprod Sci; 2008 May 01; 105(3-4):344-53. PubMed ID: 17442508 [Abstract] [Full Text] [Related]
9. [Plasma platelet-activating factor acetylhydrolase (PAF-AH) deficiency as a risk factor for stroke]. Satoh K. Brain Nerve; 2008 Nov 01; 60(11):1319-24. PubMed ID: 19069165 [Abstract] [Full Text] [Related]
10. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome. Rizos E, Tambaki AP, Gazi I, Tselepis AD, Elisaf M. Prostaglandins Leukot Essent Fatty Acids; 2005 Mar 01; 72(3):203-9. PubMed ID: 15664305 [Abstract] [Full Text] [Related]
11. Serum lipid pattern in chronic hepatitis C: histological and virological correlations. Siagris D, Christofidou M, Theocharis GJ, Pagoni N, Papadimitriou C, Lekkou A, Thomopoulos K, Starakis I, Tsamandas AC, Labropoulou-Karatza C. J Viral Hepat; 2006 Jan 01; 13(1):56-61. PubMed ID: 16364083 [Abstract] [Full Text] [Related]
12. Serum platelet-activating factor acetylhydrolase activity: a novel potential inflammatory marker in type 1 diabetes. Gomes MB, Cobas RA, Nunes E, Nery M, Castro-Faria-Neto HC, Tibiriçá E. Prostaglandins Other Lipid Mediat; 2008 Dec 01; 87(1-4):42-6. PubMed ID: 18718550 [Abstract] [Full Text] [Related]
13. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress. Noto H, Hara M, Karasawa K, Iso-O N, Satoh H, Togo M, Hashimoto Y, Yamada Y, Kosaka T, Kawamura M, Kimura S, Tsukamoto K. Arterioscler Thromb Vasc Biol; 2003 May 01; 23(5):829-35. PubMed ID: 12649088 [Abstract] [Full Text] [Related]
15. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy. Januszkiewicz-Lewandowska D, Wysocki J, Pernak M, Nowicka K, Zawada M, Rembowska J, Lewandowski K, Mańkowski P, Nowak J. Jpn J Infect Dis; 2007 Feb 01; 60(1):29-32. PubMed ID: 17314422 [Abstract] [Full Text] [Related]
16. Expression and DNA microarray analysis of a platelet activating factor-related molecule in severe pneumonia in mice due to influenza virus and bacterial co-infection. Seki M, Kosai K, Hara A, Imamura Y, Nakamura S, Kurihara S, Izumikawa K, Kakeya H, Yamamoto Y, Yanagihara K, Miyazaki Y, Mukae H, Tashiro T, Kohno S. Jpn J Infect Dis; 2009 Jan 01; 62(1):6-10. PubMed ID: 19168951 [Abstract] [Full Text] [Related]
17. Lung production of platelet-activating factor acetylhydrolase in oleic acid-induced acute lung injury. Salluh JI, Pino AV, Silva AR, Gomes RN, Souza HS, e Silva JR, Jandre FC, Giannella-Neto A, Zimmerman GA, Stafforini DM, Prescott SM, Castro-Faria-Neto HC, Bozza PT, Bozza FA. Prostaglandins Leukot Essent Fatty Acids; 2007 Jul 01; 77(1):1-8. PubMed ID: 17629689 [Abstract] [Full Text] [Related]
18. A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease. Unno N, Sakaguchi T, Nakamura T, Yamamoto N, Sugatani J, Miwa M, Konno H. J Surg Res; 2006 Jul 01; 134(1):36-43. PubMed ID: 16650870 [Abstract] [Full Text] [Related]
19. Novel mechanism for regulation of plasma platelet-activating factor acetylhydrolase expression in mammalian cells. Gardner AA, Reichert EC, Alexander TS, Topham MK, Stafforini DM. Biochem J; 2010 May 13; 428(2):269-79. PubMed ID: 20331434 [Abstract] [Full Text] [Related]
20. Profiles of HCV core protein and viremia in chronic hepatitis C: possible protective role of core antigen in liver damage. Carabaich A, Ruvoletto M, Bernardinello E, Tono N, Cavalletto L, Chemello L, Gatta A, Pontisso P. J Med Virol; 2005 May 13; 76(1):55-60. PubMed ID: 15778969 [Abstract] [Full Text] [Related] Page: [Next] [New Search]